Sobi named UK's top haemophilia company
admin 17th May 2017 Uncategorised 0Tops IPC Associates’ 2016 ranking More: Sobi named UK's top haemophilia company Source: News
read moreTops IPC Associates’ 2016 ranking More: Sobi named UK's top haemophilia company Source: News
read moreSB-525 is being developed to treat haemophilia A More: FDA to fast-track Pfizer/Sangamo gene therapy orphan drug Source: News
read moreRoche More: Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting Source: MDlinx
read moreGermany’s Boehringer Ingelheim several years ago decided it wanted to expand its biologics contract manufacturing business and bet that China was the place to target with its huge population and growing appetite for the latest meds. The company has now
read moreIt’s been just a couple of weeks since we wrote up AstraZeneca’s Imfinzi approval in bladder cancer. But so much has happened in the immuno-oncology field over that short stretch that, frankly, we at FiercePharma aren’t sure we even recognize
read moreWhen Louisiana Attorney General Jeff Landry inherited an antitrust lawsuit levied against Pfizer by his predecessor in 2015, he spotted an opportunity to combat the state’s mounting opioid epidemic. The result is a settlement for $1 million worth of Pfizer’s
read more© 1994 - 2024 B.M. Pharmaceuticals